FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,276 letters match. Newest first.

  1. www.soma4ever.com

    FDA warned soma4ever.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers online.

    High risk
  2. Sterling Distributors

    FDA warned Florida drug wholesaler Sterling Distributors for shipping prescription drugs without licenses and ignoring a counterfeit report.

    High risk
  3. www.peacefulmeds.com

    FDA warned www.peacefulmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and injectable semaglutide to U.S. consumers online.

    High risk
  4. Kenil Healthcare Private Limited

    FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.

    High risk
  5. www.buyprosoma.com

    FDA warned www.buyprosoma.com for selling unapproved, misbranded opioids and benzodiazepines to U.S. consumers online.

    High risk
  6. Zhejiang Huahai Pharmaceutical Co., Ltd.

    FDA warns Zhejiang Huahai Pharmaceutical over CGMP violations including dirty equipment, aseptic-area tape, and data integrity issues.

    High risk
  7. Horizon Tool Inc.

    FDA warns Horizon Tool over manufacturing-rule violations for AllShield E2 Sanitizing Hand Soap.

    High risk
  8. www.bigpharmausa.com

    FDA warned www.bigpharmausa.com that it sells unapproved and misbranded tramadol and oxycodone opioids to U.S. consumers online.

    High risk
  9. Nefeteri Wellness

    FDA says Nefeteri Wellness sells two unapproved colloidal silver vaginal gels promoted to treat infections.

    High risk
  10. www.buycodeine.us

    FDA warned website buycodeine.us for selling unapproved, misbranded opioid and stimulant drugs online without prescriptions.

    High risk
  11. www.24hreup.biz

    FDA warned 24hreup.biz for selling unapproved semaglutide drugs online to U.S. consumers without prescriptions.

    High risk
  12. Bio Wellness 444 LLC

    Bio Wellness 444 sold Silver Bullet and Silver D douches as unapproved new drugs for vaginal infections.

    High risk
  13. Laboratoire Druide Inc.

    FDA warned Laboratoire Druide that its OTC drugs are adulterated because of inadequate glycerin identity testing, system validation and cleaning.

    High risk
  14. Sprout Pharmaceuticals, Inc.

    FDA warned Sprout Pharmaceuticals that a CEO Instagram post for Addyi omitted risks and indication limits.

    High risk
  15. Amish Origins Management, LLC

    FDA warned Amish Origins over manufacturing quality failures and unapproved or misbranded OTC pain relief and lip balm products.

    High risk
  16. American Behavioral Research Institute, LLC

    FDA warned American Behavioral Research Institute for running a 40-subject Relaxium sleep study without an IND, treating a supplement as a drug.

    High risk
  17. CTK OTC Laboratories LLC formerly FMK LABS, Inc.

    CTK OTC Laboratories, formerly FMK Labs, failed to investigate out-of-spec results and validate processes for OTC drugs, including sunscreens.

    High risk
  18. Evi Labs LLC

    FDA warns Evi Labs over OTC drug manufacturing failures, including an antiperspirant lot above the aluminum chlorohydrate limit.

    High risk
  19. Zhejiang Easyclean Daily Chemical Co., Ltd

    FDA warned Zhejiang Easyclean Daily Chemical that its OTC drugs lacked required testing and manufacturing controls.

    High risk
  20. Rechon Life Science AB

    FDA warns Swedish sterile drugmaker Rechon Life Science over aseptic technique, weak investigations, cleaning and facility problems.

    High risk
  21. Yiling Pharmaceutical Ltd.

    FDA warns Yiling Pharmaceutical over manufacturing violations causing cross-contamination risks in finished drugs from shared equipment.

    High risk
  22. Huangshi Hygienic Material Medicine Co., Ltd.

    Huangshi Hygienic Material Medicine released U.S. drugs without identity and strength testing and lacked stability data for labeled expiration dates.

    High risk
  23. AACE Pharmaceuticals, Inc.

    AACE Pharmaceuticals distributed adulterated Lubricant PM Ointment made by CMO Brassica with CGMP violations and failed supplier qualification.

    High risk
  24. Shenzhen Hengkaifeng Commerce and Trade Co., Ltd

    Shenzhen Hengkaifeng's Sensitivity Toothpastes listing was inaccurate, making the drug misbranded, FDA says.

    Low
  25. Product Society LLC

    FDA says Product Society LLC, an OTC drugmaker in North Hollywood, California, skipped identity testing for toxic DEG/EG and process validation.

    High risk
  26. Sarfez Pharmaceuticals, Inc.

    FDA says Sarfez made false or misleading efficacy and risk claims for Soaanz (torsemide) in webpages, pamphlet, and exhibit panel.

    High risk
  27. Wuxi Medical Instrument Factory Co., Ltd.

    FDA warns Wuxi Medical Instrument Factory over insanitary conditions and manufacturing failures for sterile drugs.

    High risk
  28. NWL Netherlands Services B.V.

    FDA cites NWL Netherlands drug plant for inadequate microbial investigations, missing component identity testing, and weak lab data controls.

    High risk
  29. Excelvision Fareva

    Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.

    High risk
  30. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk
  31. OSRX, Inc.

    OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.

    High risk
  32. Mentha & Allied Products Private Ltd.

    FDA warns Mentha & Allied Products of CGMP failures that leave its APIs adulterated.

    High risk
  33. Shantou S.E.Z. Baojie Industry Co., Ltd.

    FDA warns Shantou S.E.Z. Baojie Industry over inadequate CGMP and component testing for OTC drug products, leading to Import Alert 66-40.

    High risk
  34. Tailstorm Health Inc. dba Medivant Health

    Tailstorm Health (Medivant Health) sterile compounded drugs had insanitary conditions and current good manufacturing practice failures, prompting a bevacizumab recall.

    High risk
  35. Taizhou Jingshang Cosmetics Technology Co., Ltd.

    FDA warns Taizhou Jingshang Cosmetics Technology over current good manufacturing practice failures in over-the-counter drugs, including missing identity tests for high-risk ingredients.

    High risk
  36. BioAsia Worldwide Sdn Bhd

    FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.

    High risk
  37. Nana Barseghian, M.D.

    FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.

    High risk
  38. Amazon.com, Inc.

    Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.

    High risk
  39. Cosco International, Inc.

    FDA warned Cosco International over nonprescription drug manufacturing failures and unapproved drug products.

    High risk
  40. Dyno Manufacturing, Inc.

    Dyno Manufacturing’s OTC hand sanitizer and antibacterial soap drugs lacked raw-material identity testing and other required manufacturing controls.

    High risk
  41. BEO Pharma Inc. dba BEO Pharmaceuticals Inc.

    FDA cited BEO Pharma for manufacturing quality violations, including missing identity testing of high-risk drug ingredients and releasing a batch before microbial testing.

    High risk
  42. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.

    High risk
  43. Prodose, Inc. formerly known as Spirit Pharmaceuticals LLC

    Prodose, formerly Spirit Pharmaceuticals, left a cold and flu drug mislisted; FDA calls it misbranded.

    Low
  44. Empower Clinic Services, LLC dba Empower Pharma

    FDA warns Empower Pharma over sterile drug manufacturing deficiencies, labeling, and unapproved compounded drugs after August 2024 inspection.

    High risk
  45. PMS4PMS, LLC

    FDA warns PMS4PMS of Clarence, NY, over CGMP failures and an unapproved menstrual cramp relief cream.

    High risk
  46. Naturista Store LLC

    Naturista Store sold ADVANCE KING, labeled a supplement, containing undeclared dexamethasone, diclofenac, and methocarbamol; FDA calls it an unapproved, misbranded drug.

    High risk
  47. Nubratori, Inc. dba Nubratori Rx

    FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.

    High risk
  48. www.thesafepills.org

    FDA warned www.thesafepills.org for selling unapproved, misbranded tapentadol opioid drugs to U.S. consumers online.

    High risk
  49. Americo F. Padilla, M.D.

    FDA warns clinical investigator Americo F. Padilla, M.D. over failing to obtain parental consent before enrolling pediatric subjects in drug trials.

    High risk
  50. BPI Labs, LLC

    BPI Labs distributes unapproved Epinephrine Chloride Nasal Solution in a vial FDA says can be mistaken for injectable epinephrine.

    High risk